Cargando…
Human Placental Hofbauer Cells Maintain an Anti-inflammatory M2 Phenotype despite the Presence of Gestational Diabetes Mellitus
BACKGROUND: Hofbauer cells (HBCs) are macrophages of the feto-placental unit. Despite the general view that these cells have an anti-inflammatory M2 phenotype, recent studies have claimed that pregnancy pathologies—e.g., gestational diabetes mellitus (GDM)—cause a switch from an M2 to an M1 pro-infl...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534476/ https://www.ncbi.nlm.nih.gov/pubmed/28824621 http://dx.doi.org/10.3389/fimmu.2017.00888 |
_version_ | 1783253771683364864 |
---|---|
author | Schliefsteiner, Carolin Peinhaupt, Miriam Kopp, Susanne Lögl, Jelena Lang-Olip, Ingrid Hiden, Ursula Heinemann, Akos Desoye, Gernot Wadsack, Christian |
author_facet | Schliefsteiner, Carolin Peinhaupt, Miriam Kopp, Susanne Lögl, Jelena Lang-Olip, Ingrid Hiden, Ursula Heinemann, Akos Desoye, Gernot Wadsack, Christian |
author_sort | Schliefsteiner, Carolin |
collection | PubMed |
description | BACKGROUND: Hofbauer cells (HBCs) are macrophages of the feto-placental unit. Despite the general view that these cells have an anti-inflammatory M2 phenotype, recent studies have claimed that pregnancy pathologies—e.g., gestational diabetes mellitus (GDM)—cause a switch from an M2 to an M1 pro-inflammatory phenotype in HBCs. The pilot-study presented here challenges this claim, showing that HBCs maintain anti-inflammatory properties in spite of the hyperglycemic, low-grade inflammatory environment of GDM. METHODS: HBCs were isolated from placentae of healthy women (N = 5) and women with GDM (N = 6) diagnosed in the second trimester. FACS was used to measure surface markers associated with either M1 or M2 phenotype on the cells. In addition, placental tissue sections were subjected to immune histochemical imaging to assess the phenotype within the tissue context. Supernatant from control and GDM HBCs was collected at defined time points and used in a multiplex ELISA-on-beads approach to assess secretion of cytokines, chemokines, and growth factors. The effect of HBC cell culture supernatant on placental endothelial activation was investigated. RESULTS: FACS and immune staining showed that, indeed, M2 markers, such as CD206 and CD209, are increased in HBCs isolated from GDM placentae. Also, the M1 marker CD86 was increased, but only by trend. Secretion of numerous cytokines, chemokines and growth factors was not changed; pro-inflammatory interleukin (IL)-1β and IL-6 release form GDM HBC was increased but not significant. Exposure to GDM HBC supernatant did not induce cell adhesion molecules (VCAM-1, selectins, vascular endothelial-cadherin) in placental endothelial cells compared to supernatant from control HBCs, an induction of intracellular adhesion molecule 1 was observed however. CONCLUSION: Our study—although performed in a small set of patients—shows that placental macrophages maintain their anti-inflammatory, tissue remodeling M2 phenotype even in pregnancies affected by gestational diabetes. This consistent phenotype might be important for propagation of maternal tolerance toward the fetus and for protection of the fetus from a low-grade inflammatory environment. |
format | Online Article Text |
id | pubmed-5534476 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-55344762017-08-18 Human Placental Hofbauer Cells Maintain an Anti-inflammatory M2 Phenotype despite the Presence of Gestational Diabetes Mellitus Schliefsteiner, Carolin Peinhaupt, Miriam Kopp, Susanne Lögl, Jelena Lang-Olip, Ingrid Hiden, Ursula Heinemann, Akos Desoye, Gernot Wadsack, Christian Front Immunol Immunology BACKGROUND: Hofbauer cells (HBCs) are macrophages of the feto-placental unit. Despite the general view that these cells have an anti-inflammatory M2 phenotype, recent studies have claimed that pregnancy pathologies—e.g., gestational diabetes mellitus (GDM)—cause a switch from an M2 to an M1 pro-inflammatory phenotype in HBCs. The pilot-study presented here challenges this claim, showing that HBCs maintain anti-inflammatory properties in spite of the hyperglycemic, low-grade inflammatory environment of GDM. METHODS: HBCs were isolated from placentae of healthy women (N = 5) and women with GDM (N = 6) diagnosed in the second trimester. FACS was used to measure surface markers associated with either M1 or M2 phenotype on the cells. In addition, placental tissue sections were subjected to immune histochemical imaging to assess the phenotype within the tissue context. Supernatant from control and GDM HBCs was collected at defined time points and used in a multiplex ELISA-on-beads approach to assess secretion of cytokines, chemokines, and growth factors. The effect of HBC cell culture supernatant on placental endothelial activation was investigated. RESULTS: FACS and immune staining showed that, indeed, M2 markers, such as CD206 and CD209, are increased in HBCs isolated from GDM placentae. Also, the M1 marker CD86 was increased, but only by trend. Secretion of numerous cytokines, chemokines and growth factors was not changed; pro-inflammatory interleukin (IL)-1β and IL-6 release form GDM HBC was increased but not significant. Exposure to GDM HBC supernatant did not induce cell adhesion molecules (VCAM-1, selectins, vascular endothelial-cadherin) in placental endothelial cells compared to supernatant from control HBCs, an induction of intracellular adhesion molecule 1 was observed however. CONCLUSION: Our study—although performed in a small set of patients—shows that placental macrophages maintain their anti-inflammatory, tissue remodeling M2 phenotype even in pregnancies affected by gestational diabetes. This consistent phenotype might be important for propagation of maternal tolerance toward the fetus and for protection of the fetus from a low-grade inflammatory environment. Frontiers Media S.A. 2017-07-31 /pmc/articles/PMC5534476/ /pubmed/28824621 http://dx.doi.org/10.3389/fimmu.2017.00888 Text en Copyright © 2017 Schliefsteiner, Peinhaupt, Kopp, Lögl, Lang-Olip, Hiden, Heinemann, Desoye and Wadsack. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Schliefsteiner, Carolin Peinhaupt, Miriam Kopp, Susanne Lögl, Jelena Lang-Olip, Ingrid Hiden, Ursula Heinemann, Akos Desoye, Gernot Wadsack, Christian Human Placental Hofbauer Cells Maintain an Anti-inflammatory M2 Phenotype despite the Presence of Gestational Diabetes Mellitus |
title | Human Placental Hofbauer Cells Maintain an Anti-inflammatory M2 Phenotype despite the Presence of Gestational Diabetes Mellitus |
title_full | Human Placental Hofbauer Cells Maintain an Anti-inflammatory M2 Phenotype despite the Presence of Gestational Diabetes Mellitus |
title_fullStr | Human Placental Hofbauer Cells Maintain an Anti-inflammatory M2 Phenotype despite the Presence of Gestational Diabetes Mellitus |
title_full_unstemmed | Human Placental Hofbauer Cells Maintain an Anti-inflammatory M2 Phenotype despite the Presence of Gestational Diabetes Mellitus |
title_short | Human Placental Hofbauer Cells Maintain an Anti-inflammatory M2 Phenotype despite the Presence of Gestational Diabetes Mellitus |
title_sort | human placental hofbauer cells maintain an anti-inflammatory m2 phenotype despite the presence of gestational diabetes mellitus |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534476/ https://www.ncbi.nlm.nih.gov/pubmed/28824621 http://dx.doi.org/10.3389/fimmu.2017.00888 |
work_keys_str_mv | AT schliefsteinercarolin humanplacentalhofbauercellsmaintainanantiinflammatorym2phenotypedespitethepresenceofgestationaldiabetesmellitus AT peinhauptmiriam humanplacentalhofbauercellsmaintainanantiinflammatorym2phenotypedespitethepresenceofgestationaldiabetesmellitus AT koppsusanne humanplacentalhofbauercellsmaintainanantiinflammatorym2phenotypedespitethepresenceofgestationaldiabetesmellitus AT logljelena humanplacentalhofbauercellsmaintainanantiinflammatorym2phenotypedespitethepresenceofgestationaldiabetesmellitus AT langolipingrid humanplacentalhofbauercellsmaintainanantiinflammatorym2phenotypedespitethepresenceofgestationaldiabetesmellitus AT hidenursula humanplacentalhofbauercellsmaintainanantiinflammatorym2phenotypedespitethepresenceofgestationaldiabetesmellitus AT heinemannakos humanplacentalhofbauercellsmaintainanantiinflammatorym2phenotypedespitethepresenceofgestationaldiabetesmellitus AT desoyegernot humanplacentalhofbauercellsmaintainanantiinflammatorym2phenotypedespitethepresenceofgestationaldiabetesmellitus AT wadsackchristian humanplacentalhofbauercellsmaintainanantiinflammatorym2phenotypedespitethepresenceofgestationaldiabetesmellitus |